Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNTB Connect Biopharma > Detailed Quotes

CNTB Connect Biopharma

1.080
-0.030-2.70%
Trading Session 10/05 10:12 ET
High
1.130
Open
1.100
Turnover
186.82K
Low
1.080
Pre Close
1.110
Volume
169.63K
Market Cap
59.42M
P/E(TTM)
Loss
52wk High
20.130
Shares
55.02M
P/E(Static)
Loss
52wk Low
0.557
Float Cap
20.10M
Bid/Ask %
-71.43%
Historical High
29.274
Shs Float
18.61M
Volume Ratio
2.27
Historical Low
0.557
Dividend TTM
--
Div Yield TTM
--
P/B
0.28
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.91%
Amplitude
4.51%
Avg Price
1.101
Lot Size
1
Float Cap
20.10M
Bid/Ask %
-71.43%
Historical High
29.274
Shs Float
18.61M
Volume Ratio
2.27
Historical Low
0.557
Dividend TTM
--
P/B
0.28
Dividend LFY
--
Turnover Ratio
0.91%
Amplitude
4.51%
Avg Price
1.101
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
CEO: Dr. Zheng Wei, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...